Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents.

Shah, Ami N; Metzger, Otto; Bartlett, Cynthia Huang; Liu, Yuan; Huang, Xin; Cristofanilli, Massimo

Shah, Ami N; Metzger, Otto; Bartlett, Cynthia Huang; Liu, Yuan; Huang, Xin; Cristofanilli, Massimo.

Affiliation

Shah AN; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Metzger O; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Bartlett CH; Pfizer Inc., Collegeville, Pennsylvania, USA.
Liu Y; Pfizer Oncology, San Diego, California, USA.
Huang X; Pfizer Oncology, San Diego, California, USA.
Cristofanilli M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Oncologist ; 25(6): e900-e908, 2020 06.

Article in En | MEDLINE | ID: mdl-32176406

Subject(s)

Breast Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms/drug therapy; Breast Neoplasms/genetics; Female; Hormones; Humans; Premenopause; Protein Kinase Inhibitors/therapeutic use; Receptor, ErbB-2/genetics; Receptor, ErbB-2/therapeutic use

Key words

Hormone receptor positive; Human epidermal growth factor negative; Intrinsic subtype; Metastatic breast cancer; Premenopausal

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Guideline / Risk_factors_studies Limits: Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google